MoneyWorks4Me

Gufic Biosciences - Quaterly Results

29 May 2024 Evaluate
The company witnessed a 12.69% growth in the revenue at Rs. 1949.94 millions for the quarter ended March 2024 as compared to Rs. 1730.36 millions during the year-ago period.Profit saw a slight increase of 10.73%to Rs. 200.47  millions from Rs. 181.05 millions.Operating Profit saw a handsome growth to 351.09 millions from 327.72 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1949.94 1730.36 12.69 8066.66 6906.21 16.80 8066.66 6906.21 16.80
Other Income 8.81 6.23 41.41 21.77 25.74 -15.42 21.77 25.74 -15.42
PBIDT 351.09 327.72 7.13 1480.48 1372.25 7.89 1480.48 1372.25 7.89
Interest 36.47 29.22 24.81 153.60 82.23 86.79 153.60 82.23 86.79
PBDT 314.62 298.50 5.40 1326.88 1290.02 2.86 1326.88 1290.02 2.86
Depreciation 43.42 59.18 -26.63 170.17 222.81 -23.63 170.17 222.81 -23.63
PBT 271.20 239.32 13.32 1156.71 1067.21 8.39 1156.71 1067.21 8.39
TAX 70.73 58.27 21.38 295.36 270.16 9.33 295.36 270.16 9.33
Deferred Tax -2.27 -3.73 -39.14 31.66 -11.94 -365.16 31.66 -11.94 -365.16
PAT 200.47 181.05 10.73 861.35 797.05 8.07 861.35 797.05 8.07
Equity 100.28 96.94 3.45 100.28 96.94 3.45 100.28 96.94 3.45
PBIDTM(%) 18.01 18.94 -4.93 18.35 19.87 -7.63 18.35 19.87 -7.63
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..